Sectors
DRUG
Bright Minds Biosciences Inc.
70.91
9 x 78.05
7 x 78.20
bid
ask
-
1.90
2.60%
02:11 PM
timesize
| Ytd | -9.13% | |
| 1y | 82.39% |
70.84
day range
72.13
38.00
52 week range
123.75
| Open | 71.37 | Prev Close | 72.81 | Low | 70.84 | High | 72.13 | Mkt Cap | 695.09M |
| Vol | 29.13K | Avg Vol | 288.83K | EPS | -2.05 | P/E | N/A | Forward P/E | N/A |
| Beta | -5.27 | Short Ratio | 0.70 | Inst. Own | 44.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-17 | 50-d Avg | 73.91 | 200-d Avg | 77.59 | 1yr Est | 4.87 |
| Income Statement | |||
| Operating Expenses | 11.43M | ||
| Research and Development Expense | 9.25M | ||
| Selling, General and Administrative Expense | 877.30K | ||
| Operating Income | -11.43M | ||
| Net Income | -2.40M | ||
| Net Income Common Stock | -2.40M | ||
| Net Income Common Stock (USD) | -1.69M | ||
| Consolidated Income | -2.40M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -2.40M | ||
| Earning Before Interest & Taxes (USD) | -1.69M | ||
| Weighted Average Shares | 9.83M | ||
| Weighted Average Shares Diluted | 9.83M | ||
| Balance Sheet | |||
| Cash and Equivalents | 307.83M | ||
| Cash and Equivalents (USD) | 216.70M | ||
| Current Assets | 310.28M | ||
| Property, Plant & Equipment Net | 52.92K | ||
| Total Assets | 310.34M | ||
| Current Liabilities | 2.54M | ||
| Total Liabilities | 2.54M | ||
| Accumulated Retained Earnings (Deficit) | -67.00M | ||
| Shareholders Equity | 307.79M | ||
| Shareholders Equity (USD) | 216.68M | ||
| Assets Non-Current | 52.92K | ||
| Trade and Non-Trade Payables | 2.48M | ||
| Tax Assets | 227.48K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.46K | ||
| Net Cash Flow from Financing | 83.23K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.26M | ||
| Issuance (Purchase) of Equity Shares | 109.60K | ||
| Issuance (Repayment) of Debt Securities | -26.37K | ||
| Net Cash Flow from Operations | -8.34M | ||
| Effect of Exchange Rate Changes on Cash | 6.39M | ||
| Share Based Compensation | 1.55M | ||